Quantcast
Channel: Catalent
Viewing all articles
Browse latest Browse all 54

CRS 2024 Annual Meeting and Expo

$
0
0

  1. Home
  2.  » 
Icon of a monthly calendar

CRS 2024 Annual Meeting and Expo

The CRS Annual Meeting is the yearly gathering organized by the Controlled Release Society (CRS), a global scientific society focused on the delivery science worldwide. The conference is a premier event for researchers, scientists, and pharmaceutical industry professionals involved in the development and application of controlled release technologies.

Date: July 8-12, 2024
Location: Bologna, Italy

Logo for Controlled Release Society CRS 2024 Annual Meeting and Exposition, July 8-12, 2024, Bologna, Italy

JOIN US!

Complete the form to schedule a meeting with Catalent at CRS 2024 Annual Meeting and Expo!

FEATURED SPEAKING SESSION

Title: Charting the Future of Inhalation Therapies: Innovations, Regulations, and Market Trends

Date: Thursday, July 11, 2024

Time: 2:30 pm CET

Description: Lipid-based formulations (LBFs) in softgels offer unique advantages such as improved stability, bioavailability, and enhanced absorption, yet their development is not equally common, risking missed opportunities in drug delivery optimization. This presentation will explore the strategic benefits of softgels, compare them with other bioavailability-enhancing technologies, and address challenges in developing effective dissolution methods.

SPEAKER

Karunakar Sukuru headshot

Karunakar (Karu) Sukuru, R.Ph., Ph.D.
Global Vice President
Rx Product Development
Catalent Pharma Solutions

ABOUT CATALENT

Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information www.catalent.com.

 

More products. Better treatments. Reliably supplied.™

Related Topics

We Are Looking Forward To Seeing You In Bologna!


Viewing all articles
Browse latest Browse all 54

Trending Articles